{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:57:27Z","timestamp":1787313447536,"version":"build-2736575974"},"update-to":[{"DOI":"10.1002\/14651858.cd012369","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T00:00:00Z","timestamp":1658707200000}}],"reference-count":107,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012369.pub2","type":"journal-article","created":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T10:59:17Z","timestamp":1658746757000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Antiplatelet agents for the treatment of deep venous thrombosis"],"prefix":"10.1002","volume":"2022","author":[{"given":"Carolina DQ","family":"Flumignan","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Vascular and Endovascular Surgery; Universidade Federal de S\u00e3o Paulo; S\u00e3o Paulo Brazil"},{"name":"Cochrane Brazil; Universidade Federal de S\u00e3o Paulo; S\u00e3o Paulo Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis CU","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Vascular and Endovascular Surgery; Universidade Federal de S\u00e3o Paulo; S\u00e3o Paulo Brazil"},{"name":"Cochrane Brazil; Universidade Federal de S\u00e3o Paulo; S\u00e3o Paulo Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose CC","family":"Baptista-Silva","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Vascular and Endovascular Surgery; Universidade Federal de S\u00e3o Paulo; S\u00e3o Paulo Brazil"},{"name":"Cochrane Brazil; Universidade Federal de S\u00e3o Paulo; S\u00e3o Paulo Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald LG","family":"Flumignan","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Vascular and Endovascular Surgery; Universidade Federal de S\u00e3o Paulo; S\u00e3o Paulo Brazil"},{"name":"Cochrane Brazil; Universidade Federal de S\u00e3o Paulo; S\u00e3o Paulo Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,7,25]]},"reference":[{"key":"10.1002\/14651858.CD012369.pub2-BIB0001|cit1","unstructured":"ASPIRE A multi-centre, randomised, double-blind, placebo-controlled clinical trial examining the efficacy and safety of low-dose aspirin after initial anticoagulation to prevent recurrent venous thromboembolism ctc.usyd.edu.au\/our-work\/research-divisions\/cardiovascular\/closed-trials\/aspire\/"},{"key":"10.1002\/14651858.CD012369.pub2-BIB0002|cit2","unstructured":"ASPIRE. A multi-centre, randomised, double-blind, placebo-controlled clinical trial examining the efficacy and safety of low-dose aspirin after initial anticoagulation to prevent recurrent venous thromboembolism trialsearch.who.int\/?trialid=ACTRN12605000004662"},{"key":"10.1002\/14651858.CD012369.pub2-BIB0003|cit3","unstructured":"ASPIRE A multi-centre, randomised, double-blind, placebo-controlled clinical trial examining the efficacy and safety of low-dose aspirin after initial anticoagulation to prevent recurrent venous thromboembolism anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?ACTRN=12605000004662"},{"issue":"23","key":"10.1002\/14651858.CD012369.pub2-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1161\/CIR.0b013e318278c90d","article-title":"Aspirin for the prevention of recurrent venous thromboembolism after a first unprovoked event: results of the ASPIRE randomized controlled trial. In: Late-Breaking Clinical Trial Abstracts","volume":"126","author":"Brighton","year":"2012","journal-title":"Circulation"},{"issue":"21","key":"10.1002\/14651858.CD012369.pub2-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1056\/NEJMoa1210384","article-title":"Low-dose aspirin for preventing recurrent venous thromboembolism","volume":"367","author":"Brighton","year":"2012","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD012369.pub2-BIB0006|cit6","unstructured":"Brighton TA Eikelboom JW Mann K Mister R Gallus A Ockelford P Protocol to 'Low-dose aspirin for preventing recurrent venous thromboembolism' www.nejm.org\/doi\/suppl\/10.1056\/NEJMoa1210384\/suppl_file\/nejmoa1210384_protocol.pdf"},{"key":"10.1002\/14651858.CD012369.pub2-BIB0007|cit7","unstructured":"Brighton TA Eikelboom JW Mann K Mister R Gallus A Ockelford P Supplementary Appendix to 'Low-dose aspirin for preventing recurrent venous thromboembolism' www.nejm.org\/doi\/suppl\/10.1056\/NEJMoa1210384\/suppl_file\/nejmoa1210384_appendix.pdf"},{"key":"10.1002\/14651858.CD012369.pub2-BIB0008|cit8","unstructured":"Robledo K DVT subgroup data used in our trial [personal communication] Email to: CDQ Flumignan"},{"issue":"4","key":"10.1002\/14651858.CD012369.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1177\/000331979304400410","article-title":"Prevention of recurrent deep venous thrombosis with indobufen. A 3-year follow-up study using color duplex scanning","volume":"44","author":"Belcaro","year":"1993","journal-title":"Angiology"},{"issue":"9","key":"10.1002\/14651858.CD012369.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/000331979304400904","article-title":"Prophylaxis of recurrent deep venous thrombosis. A randomized, prospective study using indobufen and graduated elastic compression stockings","volume":"44","author":"Belcaro","year":"1993","journal-title":"Angiology"},{"issue":"6","key":"10.1002\/14651858.CD012369.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0049-3848(95)00081-2","article-title":"The treatment of severe or recurrent deep venous thrombosis. Beneficial effect of the co-administration of antiplatelet agents with or without rheological effects, and anticoagulants","volume":"78","author":"Moriau","year":"1995","journal-title":"Thrombosis Research"},{"issue":"8208-8209","key":"10.1002\/14651858.CD012369.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0140-6736(80)92396-X","article-title":"Trial of dipyridamole-aspirin in recurring venous thrombosis","volume":"2","author":"Steele","year":"1980","journal-title":"Lancet (London, England)"},{"issue":"3","key":"10.1002\/14651858.CD012369.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0002-9343(78)90230-9","article-title":"Effects of platelet suppressant, anticoagulant and fibrinolytic therapy in patients with recurrent venous thrombosis","volume":"64","author":"Steele","year":"1978","journal-title":"American Journal of Medicine"},{"issue":"21","key":"10.1002\/14651858.CD012369.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1182\/blood.V118.21.543.543","article-title":"Aspirin after oral anticoagulants for prevention of recurrence in patients with unprovoked venous thromboembolism. the WARFASA study","volume":"118","author":"Becattini","year":"2011","journal-title":"Blood"},{"issue":"16","key":"10.1002\/14651858.CD012369.pub2-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1056\/NEJMx120070","article-title":"Aspirin for preventing the recurrence of venous thromboembolism: correction","volume":"367","author":"Becattini","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"21","key":"10.1002\/14651858.CD012369.pub2-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1056\/NEJMoa1114238","article-title":"Aspirin for preventing the recurrence of venous thromboembolism","volume":"366","author":"Becattini","year":"2012","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD012369.pub2-BIB0017|cit17","doi-asserted-by":"crossref","unstructured":"Becattini C Agnelli G Schenone A Eichinger S Bucherini E Silingardi M Supplementary appendix to 'Aspirin for preventing the recurrence of venous thromboembolism' www.nejm.org\/doi\/suppl\/10.1056\/NEJMoa1114238\/suppl_file\/nejmoa1114238_appendix.pdf 2012 (accessed 7 January 2017)","DOI":"10.1097\/OGX.0b013e31827760a8"},{"key":"10.1002\/14651858.CD012369.pub2-BIB0018|cit18","unstructured":"Aspirin after six months or one year of oral anticoagulants for the prevention of recurrent venous thromboembolism in patients with idiopathic venous thromboembolism. The WARFASA Study clinicaltrials.gov\/ct2\/show\/NCT00222677"},{"issue":"1","key":"10.1002\/14651858.CD012369.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1055\/s-0038-1652224","article-title":"THe effect of piracetam in preventing recurrent deep venous thrombosis","volume":"46","author":"Bick","year":"1981","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD012369.pub2-BIB0020|cit20","unstructured":"Reduced-dosed rivaroxaban and standard-dosed rivaroxaban versus ASA in the long-term prevention of recurrent symptomatic venous thromboembolism in patients with symptomatic deep-vein thrombosis and\/or pulmonary embolism (The Einstein Choice Study) clinicaltrialsregister.eu\/ctr-search\/trial\/2013-000619-26\/AT"},{"key":"10.1002\/14651858.CD012369.pub2-BIB0021|cit21","unstructured":"Reduced-dosed rivaroxaban and standard-dosed rivaroxaban versus ASA in the long-term prevention of recurrent symptomatic venous thromboembolism in patients with symptomatic deep-vein thrombosis and\/or pulmonary embolism. The Einstein Choice Study - Reduced-dosed rivaroxaban in the long-term prevention of recurrent symptomatic VTE trialsearch.who.int\/?trialid=EUCTR2013-000619-26-HU"},{"key":"10.1002\/14651858.CD012369.pub2-BIB0022|cit22","unstructured":"Reduced-dosed rivaroxaban and standard-dosed rivaroxaban versus ASA in the long-term prevention of recurrent symptomatic venous thromboembolism in patients with symptomatic deep-vein thrombosis and\/or pulmonary embolism clinicaltrials.gov\/ct2\/show\/NCT02064439"},{"key":"10.1002\/14651858.CD012369.pub2-BIB0023|cit23","unstructured":"Reduced-dosed rivaroxaban and standard-dosed rivaroxaban versus aspirin in the long-term prevention of blood clots from recurring in the leg or lung explorer.opentrials.net\/trials\/cc5722b3-d0bc-4a7d-a9d1-35d8391aac9c 2014 (accessed 4 December 2016)"},{"issue":"3","key":"10.1002\/14651858.CD012369.pub2-BIB0024|cit24","first-page":"645","article-title":"Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism. Rationale for and design of the EINSTEIN CHOICE study","volume":"114","author":"Weitz","year":"2015","journal-title":"Thrombosis and Haemostasis"},{"issue":"13","key":"10.1002\/14651858.CD012369.pub2-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1056\/NEJMoa1700518","article-title":"Rivaroxaban or aspirin for extended treatment of venous thromboembolism","volume":"376","author":"Weitz","year":"2017","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD012369.pub2-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1159\/000395715","volume-title":"Platelets, drugs and thrombosis","author":"Evans","year":"1975"},{"key":"10.1002\/14651858.CD012369.pub2-BIB0027|cit27","unstructured":"Comparison of the effectiveness of aspirin with enoxaparin sodium for prevention of deep vein thrombosis in tibial fractures en.irct.ir\/trial\/49703"},{"issue":"1","key":"10.1002\/14651858.CD012369.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-0038-1657118","article-title":"Clinical and biological activity of the antiplatelet agent suloctidil in treatment of idiopathic recurrent vein thrombosis (I.R.V.T.)","volume":"47","author":"Moriau","year":"1982","journal-title":"Thrombosis and Haemostasis"},{"issue":"1","key":"10.1002\/14651858.CD012369.pub2-BIB0029|cit29","first-page":"233","article-title":"Anticoagulant therapy in deep venous thrombosis. A randomized controlled study","volume":"54","author":"Nielsen","year":"1985","journal-title":"Thrombosis and Haemostasis"},{"issue":"3-4","key":"10.1002\/14651858.CD012369.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0049-3848(94)90100-7","article-title":"Anticoagulant therapy in deep venous thrombosis. A randomized controlled study","volume":"73","author":"Nielsen","year":"1994","journal-title":"Thrombosis Research"},{"issue":"5","key":"10.1002\/14651858.CD012369.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-2796.1994.tb01103.x","article-title":"Silent pulmonary embolism in patients with deep venous thrombosis. Incidence and fate in a randomized, controlled trial of anticoagulation versus no anticoagulation","volume":"235","author":"Nielsen","year":"1994","journal-title":"Journal of Internal Medicine"},{"issue":"11","key":"10.1002\/14651858.CD012369.pub2-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"e031657","DOI":"10.1136\/bmjopen-2019-031657","article-title":"CRISTAL: protocol for a cluster randomised, crossover, non-inferiority trial of aspirin compared to low molecular weight heparin for venous thromboembolism prophylaxis in hip or knee arthroplasty, a registry nested study","volume":"9","author":"Sidhu","year":"2019","journal-title":"BMJ Open"},{"issue":"1","key":"10.1002\/14651858.CD012369.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1186\/s13063-021-05486-0","article-title":"CRISTAL (a cluster-randomised, crossover, non-inferiority trial of aspirin compared to low molecular weight heparin for venous thromboembolism prophylaxis in hip or knee arthroplasty, a registry nested study): statistical analysis plan","volume":"22","author":"Sidhu","year":"2021","journal-title":"Trials"},{"issue":"5","key":"10.1002\/14651858.CD012369.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/archinte.1991.00400050081016","article-title":"A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study","volume":"151","author":"Wheeler","year":"1991","journal-title":"Archives of Internal Medicine"},{"issue":"9","key":"10.1002\/14651858.CD012369.pub2-BIB0035|cit35","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004174.pub3","article-title":"Compression therapy for prevention of post-thrombotic syndrome","author":"Appelen","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"18","key":"10.1002\/14651858.CD012369.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"980","DOI":"10.12968\/bjon.2006.15.18.22021","article-title":"Evidence for the prevention of venous thromboembolism","volume":"15","author":"Autar","year":"2006","journal-title":"British Journal of Nursing"},{"issue":"24","key":"10.1002\/14651858.CD012369.pub2-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"e29367","DOI":"10.1097\/MD.0000000000029367","article-title":"External validation of Villalta score in high-middle income country patients with deep vein thrombosis","volume":"101","author":"\u00c1vila","year":"2022","journal-title":"Medicine"},{"issue":"21","key":"10.1002\/14651858.CD012369.pub2-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1056\/NEJMoa1114238","article-title":"Aspirin for preventing the recurrence of venous thromboembolism","volume":"366","author":"Becattini","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD012369.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/000331979304400904","article-title":"Prophylaxis of recurrent deep venous thrombosis. A randomized, prospective study using indobufen and graduated elastic compression stockings","volume":"44","author":"Belcaro","year":"1993","journal-title":"Angiology"},{"issue":"3","key":"10.1002\/14651858.CD012369.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0750-7658(05)80370-3","article-title":"Prevention of venous thrombosis with antiplatelet agents","volume":"11","author":"Boneu","year":"1992","journal-title":"Annales Francaises d'Anesthesie et de Reanimation"},{"key":"10.1002\/14651858.CD012369.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"d3036","DOI":"10.1136\/bmj.d3036","article-title":"Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials","volume":"342","author":"Boutitie","year":"2011","journal-title":"BMJ (Clinical Research ed.)"},{"issue":"19","key":"10.1002\/14651858.CD012369.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.jacc.2011.06.059","article-title":"Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data","volume":"58","author":"Brar","year":"2011","journal-title":"Journal of the American College of Cardiology"},{"issue":"7","key":"10.1002\/14651858.CD012369.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/eurheartj\/ehr452","article-title":"The rise of cardiovascular medicine","volume":"33","author":"Braunwald","year":"2012","journal-title":"European Heart Journal"},{"issue":"21","key":"10.1002\/14651858.CD012369.pub2-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1056\/NEJMoa1210384","article-title":"Low-dose aspirin for preventing recurrent venous thromboembolism","volume":"367","author":"Brighton","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012369.pub2-BIB0045|cit45","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002783.pub5","article-title":"Thrombolytic strategies versus standard anticoagulation for acute deep vein thrombosis of the lower limb","author":"Broderick","year":"2021","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012369.pub2-BIB0046|cit46","first-page":"f5133","article-title":"Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis","volume":"347","author":"Castellucci","year":"2013","journal-title":"BMJ (Clinical research ed.)"},{"issue":"5","key":"10.1002\/14651858.CD012369.pub2-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1590\/S1676-24442006000500004","article-title":"Platelets: still a therapeutical target","volume":"42","author":"Castro","year":"2006","journal-title":"Jornal Brasileiro de Patologia e Medicina Laboratorial"},{"issue":"1","key":"10.1002\/14651858.CD012369.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/anae.15563","article-title":"SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study","volume":"77","author":"COVIDSurg Collaborative","year":"2022","journal-title":"Anaesthesia"},{"key":"10.1002\/14651858.CD012369.pub2-BIB0049|cit49","unstructured":"Deeks JJ Higgins JP Altman DG Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD012369.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1258\/phleb.2011.012s06","article-title":"Incidence and risk factors of the post-thrombotic syndrome","volume":"27 Suppl 1","author":"Wolf","year":"2012","journal-title":"Phlebology\/Venous Forum of the Royal Society of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012369.pub2-BIB0051|cit51","first-page":"9","article-title":"A randomized pilot trial for aggressive therapeutic approaches in aspirin-resistant patients undergoing percutaneous coronary intervention","volume":"23","author":"El-Atat","year":"2011","journal-title":"Journal of Invasive Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD012369.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD012369.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1055\/s-2007-994919","article-title":"Pathophysiology of the thrombophilic state in the cancer patient","volume":"25","author":"Falanga","year":"1999","journal-title":"Seminars in Thrombosis and Hemostasis"},{"issue":"1","key":"10.1002\/14651858.CD012369.pub2-BIB0054|cit54","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011468","article-title":"Angioplasty for deep venous thrombosis","author":"Flumignan","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD012369.pub2-BIB0055|cit55","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013739.pub2","article-title":"Anticoagulants for people hospitalised with COVID-19","author":"Flumignan","year":"2022","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD012369.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.revmed.2012.05.012","article-title":"Epidemiology and management of isolated distal deep venous thrombosis","volume":"33","author":"Galanaud","year":"2012","journal-title":"La Revue de M\u00e9decine Interne\/fondee par la Societ\u00e9 nationale Fran\u00e7aise de M\u00e9decine Interne"},{"issue":"3","key":"10.1002\/14651858.CD012369.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.beha.2012.06.007","article-title":"Venous thromboembolism: epidemiology and magnitude of the problem","volume":"25","author":"Goldhaber","year":"2012","journal-title":"Best Practice and Research. Clinical Haematology"},{"issue":"18","key":"10.1002\/14651858.CD012369.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1001\/archinte.164.18.1965","article-title":"Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review","volume":"164","author":"Gomes","year":"2004","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD012369.pub2-BIB0059|cit59","unstructured":"GRADEpro GDT Guideline Development Tool McMaster University (developed by Evidence Prime) 2015"},{"issue":"7454","key":"10.1002\/14651858.CD012369.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"GRADE Working Group","year":"2004","journal-title":"BMJ (Clinical Research ed.)"},{"issue":"372","key":"10.1002\/14651858.CD012369.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"321","DOI":"10.53738\/REVMED.2013.9.372.0321","article-title":"Post-thrombotic syndrome: the forgotten complication of venous thromboembolism","volume":"9","author":"Guanella","year":"2013","journal-title":"Revue M\u00e9dicale Suisse"},{"key":"10.1002\/14651858.CD012369.pub2-BIB0062|cit62","doi-asserted-by":"crossref","unstructured":"Handoll HH Langhorne P In defence of reviews of small trials: underpinning the generation of evidence to inform practice Cochrane Database of Systematic Reviews 2015 11 10.1002\/14651858.ED000106","DOI":"10.1002\/14651858.ED000106"},{"issue":"6","key":"10.1002\/14651858.CD012369.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archinte.160.6.809","article-title":"Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study","volume":"160","author":"Heit","year":"2000","journal-title":"Archives of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012369.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/ATVBAHA.108.162545","article-title":"The epidemiology of venous thromboembolism in the community","volume":"28","author":"Heit","year":"2008","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"7414","key":"10.1002\/14651858.CD012369.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ (Clinical Research ed.)"},{"key":"10.1002\/14651858.CD012369.pub2-BIB0066|cit66","unstructured":"Higgins JP Altman DG Sterne JA Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). Cochrane, 2017 Available from www.training.cochrane.org\/handbook\/archive\/v5.2"},{"key":"10.1002\/14651858.CD012369.pub2-BIB0067|cit67","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Welch VA Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook"},{"issue":"5","key":"10.1002\/14651858.CD012369.pub2-BIB0068|cit68","first-page":"843","article-title":"Thrombosis: a major contributor to global disease burden","volume":"112","author":"ISTH Steering Committee for World Thrombosis Day","year":"2014","journal-title":"Thrombosis and Haemostasis"},{"issue":"1","key":"10.1002\/14651858.CD012369.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejvs.2020.09.023","article-title":"Editor's Choice - European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the management of venous thrombosis","volume":"61","author":"Kakkos","year":"2021","journal-title":"European Journal of Vacular and Endovascular Surgery"},{"key":"10.1002\/14651858.CD012369.pub2-BIB0070|cit70","unstructured":"Lefebvre C Glanville J Briscoe S Littlewood A Marshall C Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD012369.pub2-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD012369.pub2-BIB0072|cit72","first-page":"172","article-title":"Resistance to acetylsalicylic acid and to clopidogrel: an emergent clinical entity","volume":"15","author":"Lugo","year":"2008","journal-title":"Revista Colombiana de Cardiolog\u00eda"},{"issue":"11","key":"10.1002\/14651858.CD012369.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"e0143252","DOI":"10.1371\/journal.pone.0143252","article-title":"Extended anticoagulant and aspirin treatment for the secondary prevention of thromboembolic disease: a systematic review and meta-analysis","volume":"10","author":"Marik","year":"2015","journal-title":"PloS one"},{"issue":"6","key":"10.1002\/14651858.CD012369.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.jvs.2008.07.055","article-title":"Incidence of ipsilateral postoperative deep venous thrombosis in the amputated lower extremity of patients with peripheral obstructive arterial disease","volume":"48","author":"Matielo","year":"2008","journal-title":"Journal of Vascular Surgery"},{"issue":"4","key":"10.1002\/14651858.CD012369.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1055\/s-2005-916672","article-title":"Platelet function tests and flow cytometry to monitor antiplatelet therapy","volume":"31","author":"Matzdorff","year":"2005","journal-title":"Seminars in Thrombosis and Hemostasis"},{"issue":"4","key":"10.1002\/14651858.CD012369.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1055\/s-0038-1657712","article-title":"Risk factors for pregnancy associated venous thromboembolism","volume":"78","author":"McColl","year":"1997","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD012369.pub2-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD012369.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2007.02450.x","article-title":"Incidence and mortality of venous thrombosis: a population-based study","volume":"5","author":"Naess","year":"2007","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD012369.pub2-BIB0079|cit79","unstructured":"National Institute for Health and Care Excellence Venous thromboembolic diseases: diagnosis, management and thrombophilia testing Available from www.nice.org.uk\/guidance\/ng158"},{"issue":"1","key":"10.1002\/14651858.CD012369.pub2-BIB0080|cit80","first-page":"1","article-title":"Prevention of venous thromboembolism. International Consensus Statement. Guidelines compiled in accordance with the scientific evidence","volume":"20","author":"Nicolaides","year":"2001","journal-title":"International Angiology"},{"issue":"3","key":"10.1002\/14651858.CD012369.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.blre.2011.01.007","article-title":"Effectiveness and safety of combined antiplatelet and anticoagulant therapy: a critical review of the evidence from randomized controlled trials","volume":"25","author":"Paikin","year":"2011","journal-title":"Blood Reviews"},{"key":"10.1002\/14651858.CD012369.pub2-BIB0082|cit82","unstructured":"Review Manager 5 (RevMan 5) Nordic Cochrane Centre, The Cochrane Collaboration 2020"},{"issue":"6","key":"10.1002\/14651858.CD012369.pub2-BIB0083|cit83","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010956.pub2","article-title":"Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of deep vein thrombosis","author":"Robertson","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD012369.pub2-BIB0084|cit84","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011536.pub2","article-title":"Pharmacomechanical thrombectomy for iliofemoral deep vein thrombosis","author":"Robertson","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD012369.pub2-BIB0085|cit85","first-page":"1","article-title":"Venous thrombosis: the role of genes, environment, and behavior","volume":"2005","author":"Rosendaal","year":"2005","journal-title":"Hematology\/the Education Program of the American Society of Hematology. American Society of Hematology. Education Program"},{"issue":"3","key":"10.1002\/14651858.CD012369.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD012369.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2017.04.052","article-title":"Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015","volume":"70","author":"Roth","year":"2017","journal-title":"Journal of the American College of Cardiology"},{"issue":"22","key":"10.1002\/14651858.CD012369.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1001\/archinte.160.22.3415","article-title":"An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study","volume":"160","author":"Samama","year":"2000","journal-title":"Archives of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012369.pub2-BIB0089|cit89","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015102","article-title":"Prophylactic anticoagulants for non-hospitalised people with COVID-19","author":"Santos","year":"2022","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD012369.pub2-BIB0090|cit90","first-page":"84","article-title":"Aspirin and venous thromboses","volume":"56","author":"Schror","year":"2015","journal-title":"Der Internist"},{"issue":"4","key":"10.1002\/14651858.CD012369.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"1","key":"10.1002\/14651858.CD012369.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1538-7836.2009.03678.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients","volume":"8","author":"Schulman","year":"2010","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD012369.pub2-BIB0093|cit93","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013 Available from gdt.guidelinedevelopment.org\/app\/handbook\/handbook.html"},{"key":"10.1002\/14651858.CD012369.pub2-BIB0094|cit94","unstructured":"Schu\u0308nemann HJ Vist GE Higgins JP Santesso N Deeks JJ Glasziou P Chapter 15: Interpreting results and drawing conclusions. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD012369.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/bjs.18004821103","article-title":"Venous thrombosis and pulmonary embolism. A clinico-pathological study in injured and burned patients","volume":"48","author":"Sevitt","year":"1961","journal-title":"British Journal of Surgery"},{"issue":"13","key":"10.1002\/14651858.CD012369.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1161\/CIRCULATIONAHA.114.008828","article-title":"Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration","volume":"130","author":"Simes","year":"2014","journal-title":"Circulation"},{"issue":"5","key":"10.1002\/14651858.CD012369.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.thromres.2015.02.032","article-title":"Comparative efficacy and safety of anticoagulants and aspirin for extended treatment of venous thromboembolism: a network meta-analysis","volume":"135","author":"Sobieraj","year":"2015","journal-title":"Thrombosis Research"},{"issue":"1","key":"10.1002\/14651858.CD012369.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jvs.2012.09.011","article-title":"Scoring systems for the post-thrombotic syndrome","volume":"57","author":"Soosainathan","year":"2013","journal-title":"Journal of Vascular Surgery"},{"issue":"6","key":"10.1002\/14651858.CD012369.pub2-BIB0099|cit99","doi-asserted-by":"publisher","first-page":"e545","DOI":"10.1016\/j.chest.2021.07.055","article-title":"Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report","volume":"160","author":"Stevens","year":"2021","journal-title":"Chest"},{"issue":"9","key":"10.1002\/14651858.CD012369.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"832.e13","DOI":"10.1016\/j.amjmed.2013.02.024","article-title":"Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE study cohort","volume":"126","author":"Tagalakis","year":"2013","journal-title":"American Journal of Medicine"},{"issue":"10","key":"10.1002\/14651858.CD012369.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1001\/archinte.162.10.1182","article-title":"Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology","volume":"162","author":"Tsai","year":"2002","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD012369.pub2-BIB0102|cit102","unstructured":"Consolidated list of products: whose consumption and\/or sale have been banned, withdrawn, severely restricted or not approved by governments Economic & Social Affairs 2005 12 251"},{"issue":"4","key":"10.1002\/14651858.CD012369.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/oxfordjournals.bja.a013468","article-title":"General versus regional anaesthesia for hip fracture surgery: a meta-analysis of randomized trials","volume":"84","author":"Urwin","year":"2000","journal-title":"British Journal of Anaesthesia"},{"issue":"7 Suppl","key":"10.1002\/14651858.CD012369.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"S391","DOI":"10.1016\/j.jvir.2009.04.034","article-title":"Reporting standards for endovascular treatment of lower extremity deep vein thrombosis","volume":"20","author":"Vedantham","year":"2009","journal-title":"Journal of Vascular and Interventional Radiology"},{"issue":"1","key":"10.1002\/14651858.CD012369.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00281-011-0286-4","article-title":"Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum","volume":"34","author":"Vieira-de-Abreu","year":"2012","journal-title":"Seminars in Immunopathology"},{"issue":"2","key":"10.1002\/14651858.CD012369.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.blre.2007.11.001","article-title":"Aspirin and other antiplatelet drugs in the prevention of venous thromboembolism","volume":"22","author":"Watson","year":"2008","journal-title":"Blood Reviews"},{"issue":"9","key":"10.1002\/14651858.CD012369.pub2-BIB0107|cit107","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012369","article-title":"Antiplatelet agents for the treatment of deep venous thrombosis","author":"Flumignan","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T14:25:47Z","timestamp":1761143147000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012369.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Vascular Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,7,25]]},"references-count":107,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012369.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,25]]}}}